Day FR, Thompson DJ, Helgason H, et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017;49(6):834-841. doi:10.1038/ng.3841.

Taylor AM, Shih J, Ha G, et al. Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell. 2018;33(4):676-689.e3. doi:10.1016/j.ccell.2018.03.007.

Huang K- lin, Mashl J, Wu Y, et al. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell. 2018;173(2):355-370.e14. doi:10.1016/j.cell.2018.03.039.

Jégou B, Sankararaman S, Rolland AD, Reich D, Chalmel F. Meiotic Genes Are Enriched in Regions of Reduced Archaic Ancestry. Mol Biol Evol. 2017;34(8):1974-1980. doi:10.1093/molbev/msx141.

Li H, Bloom JM, Farjoun Y, et al. A synthetic-diploid benchmark for accurate variant-calling evaluation. Nat Methods. 2018;15(8):595-597. doi:10.1038/s41592-018-0054-7.

Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018;173(2):321-337.e10. doi:10.1016/j.cell.2018.03.035.

Vis DJ, Lewin J, Liao RG, et al. Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape. Ann Oncol. 2017;28(5):1145-1151. doi:10.1093/annonc/mdx037.

Yang Y, Zhao H, Boomsma DI, et al. Molecular genetic overlap between migraine and major depressive disorder. Eur J Hum Genet. 2018;26(8):1202-1216. doi:10.1038/s41431-018-0150-2.

Ding L, Bailey MH, Porta-Pardo E, et al. Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell. 2018;173(2):305-320.e10. doi:10.1016/j.cell.2018.03.033.

Hormozdiari F, Zhu A, Kichaev G, et al. Widespread Allelic Heterogeneity in Complex Traits. Am J Hum Genet. 2017;100(5):789-802. doi:10.1016/j.ajhg.2017.04.005.